CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Similarly, Zepbound is Mounjaro’s weight-loss counterpart ... said many of his patients report life-changing weight loss while on GLP-1 medications. “I have some veterans who have lost ...